• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[隐匿性乳腺癌的免疫组织化学诊断]

[Immunohistochemical diagnosis of occult breast cancer].

作者信息

Schmitz F J, Bosse U

出版信息

Geburtshilfe Frauenheilkd. 1987 Apr;47(4):249-53. doi: 10.1055/s-2008-1035817.

DOI:10.1055/s-2008-1035817
PMID:3036640
Abstract

The techniques associated with immunohistochemistry are of major interest in modern tumour diagnosis. Their simple application provides a wider scope for diagnosis by increasing the possibilities of characterising tumour cells. In particular, the combination of various tumour markers has led to a better understanding of tumour histogenesis. If the primary tumour is unknown and only metastases are available for diagnosis, further important information can be gained allowing a correlation with the origin of the metastases. In three own cases an occult carcinoma of the female breast could be diagnosed pre-operatively via immunohistochemistry techniques. Since no marker is available that reacts specifically with cells of metastasizing mammary cancer, lymph node metastases have been examined with several different markers. For that purpose, the epithelial membrane antigen (EMA), Thomsen-Friedenreich-antigen (T-Ag) and alpha-lactalbumin (ALA) have been used to point out several pathways of cell metabolism. It could be demonstrated that the prospective use of the three markers is of the highest value to make diagnosis easier and safer than by interpreting the morphological appearance. The diagnostic value of tumour markers is an important step forward, especially in the interpretation of tumour cell embolism, macrometastases and micrometastases in regional lymph nodes.

摘要

免疫组织化学相关技术在现代肿瘤诊断中备受关注。其简单应用通过增加肿瘤细胞特征化的可能性,为诊断提供了更广阔的空间。特别是,多种肿瘤标志物的联合使用使人们对肿瘤组织发生有了更好的理解。如果原发性肿瘤未知,仅能对转移灶进行诊断,那么通过免疫组织化学技术可以获得更多重要信息,从而将转移灶与原发部位联系起来。在我们自己的三例病例中,通过免疫组织化学技术在术前诊断出了隐匿性乳腺癌。由于没有一种标志物能特异性地与转移性乳腺癌细胞反应,因此我们用几种不同的标志物对淋巴结转移灶进行了检测。为此,上皮膜抗原(EMA)、汤姆森-弗里德赖希抗原(T-Ag)和α-乳白蛋白(ALA)被用于指出细胞代谢的几种途径。结果表明,与仅通过形态学表现进行判断相比,联合使用这三种标志物对于更轻松、更安全地进行诊断具有极高的价值。肿瘤标志物的诊断价值是向前迈出的重要一步,尤其在解释区域淋巴结中的肿瘤细胞栓塞、大转移灶和微转移灶方面。

相似文献

1
[Immunohistochemical diagnosis of occult breast cancer].[隐匿性乳腺癌的免疫组织化学诊断]
Geburtshilfe Frauenheilkd. 1987 Apr;47(4):249-53. doi: 10.1055/s-2008-1035817.
2
[Lymph node metastasis of a "squamous cell carcinoma" as a manifestation of occult breast cancer].[“鳞状细胞癌”的淋巴结转移作为隐匿性乳腺癌的一种表现]
Pathologe. 1988 Sep;9(5):309-12.
3
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.前哨淋巴结作为乳腺癌患者治疗规划的新标志物。
J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022.
4
Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.乳腺癌隐匿性区域淋巴结转移:应用CAM 5.2和NCRC-11抗体进行免疫组织学检测
J Pathol. 1991 Nov;165(3):221-7. doi: 10.1002/path.1711650305.
5
[Histological structure of the primary tumor and status of the regional lymph nodes in breast cancer].[乳腺癌原发肿瘤的组织学结构及区域淋巴结状况]
Geburtshilfe Frauenheilkd. 1984 Nov;44(11):710-4. doi: 10.1055/s-2008-1036505.
6
The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases.单克隆抗体在乳腺腋窝微转移灶组织病理学检测中的应用。
Eur J Surg Oncol. 1987 Oct;13(5):409-11.
7
[Micrometastases in axillary lymph nodes in breast cancer].[乳腺癌腋窝淋巴结中的微转移灶]
Gynakol Rundsch. 1989;29 Suppl 2:234-6.
8
[Micrometastases of the axillary lymph nodes in breast cancer. An immunohistochemical study].[乳腺癌腋窝淋巴结微转移。一项免疫组织化学研究]
Pathologe. 1989 Sep;10(5):289-93.
9
Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.通过前瞻性使用免疫组织化学法测定原发性乳腺癌前哨淋巴结(SLN)状态可提高微转移和孤立肿瘤细胞的检出率:174例患者前哨淋巴结活检后的分析
Eur J Surg Oncol. 2007 Feb;33(1):33-8. doi: 10.1016/j.ejso.2006.11.007. Epub 2006 Dec 15.
10
Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients.淋巴结阴性乳腺癌患者淋巴结转移的免疫组化检测
Anticancer Res. 2001 Jan-Feb;21(1B):697-9.